MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajo.2017.08.017

Медицинская библиотека · American journal of ophthalmology · 2017

Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.

Sarens Inge L, Casteels Ingele, Anton Jordi, Bader-Meunier Brigitte, Brissaud Philippe, Chédeville Gaelle, Cimaz Rolando, Dick Andrew D, Espada Graciella, Fernandez-Martin Jorge, Guly Catherine M, Hachulla Eric, Harjacek Miroslav, Khubchandani Raju, Mackensen Friederike, Merino Rosa, Modesto Consuelo, Naranjo Antonio, Oliveira-Knupp Sheila, Özen Seza, Pajot Christine, Ramanan Athimalaipet V, Russo Ricardo, Susic Gordana, Thatayatikom Akaluck, Thomée Caroline, Vastert Sebastiaan, Bertin John, Arostegui Juan I, Rose Carlos D, Wouters Carine H

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: Provide baseline and preliminary follow-up results in a 5-year longitudinal study of Blau syndrome.

DESIGN

Multicenter, prospective interventional case series.

METHODS

Baseline data from 50 patients from 25 centers worldwide, and follow-up data for patients followed 1, 2, or 3 years at the end of study enrollment. Ophthalmic data were collected at baseline and yearly visits by means of a standardized collection form.

RESULTS

Median age at onset of eye disease was 60 months and duration of eye disease at baseline 145 months. At baseline 38 patients (78%) had uveitis, which was bilateral in 37 (97%). Eight patients (21%) had moderate to severe visual impairment. Panuveitis was found in 38 eyes (51%), with characteristic multifocal choroidal infiltrates in 29 eyes (39%). Optic disc pallor in 9 eyes (12%) and peripapillary nodules in 9 eyes (12%) were the commonest signs of optic nerve involvement. Active anterior chamber inflammation was noted in 30 eyes (40%) at baseline and in 16 (34%), 17 (57%), and 11 (61%) eyes at 1, 2, and 3 years, respectively. Panuveitis was associated with longer disease duration. At baseline, 56 eyes (75%) were on topical corticosteroids. Twenty-six patients (68%) received a combination of systemic corticosteroids and immunomodulatory therapy.

CONCLUSIONS

Blau uveitis is characterized by progressive panuveitis with multifocal choroiditis, resulting in severe ocular morbidity despite continuous systemic and local immunomodulatory therapy. The frequency and severity of Blau uveitis highlight the need for close ophthalmologic surveillance as well as a search for more effective therapies.

Для цитирования: Sarens Inge L, Casteels Ingele, Anton Jordi, Bader-Meunier Brigitte, Brissaud Philippe, Chédeville Gaelle, Cimaz Rolando, Dick Andrew D, Espada Graciella, Fernandez-Martin Jorge, Guly Catherine M, Hachulla Eric, Harjacek Miroslav, Khubchandani Raju, Mackensen Friederike, Merino Rosa, Modesto Consuelo, Naranjo Antonio, Oliveira-Knupp Sheila, Özen Seza, Pajot Christine, Ramanan Athimalaipet V, Russo Ricardo, Susic Gordana, Thatayatikom Akaluck, Thomée Caroline, Vastert Sebastiaan, Bertin John, Arostegui Juan I, Rose Carlos D, Wouters Carine H. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.. American journal of ophthalmology. 2017. DOI: 10.1016/j.ajo.2017.08.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.